Maternal embryonic leucine zipper kinase is stabilized in mitosis by phosphorylation and is partially degraded upon mitotic exit

Experimental Cell Research

Volumn 316, Issue 13, 2010, Pages 2166-2173

  Badouel, Caroline ^a,b   Chartrain, Isabelle ^a   Blot, Joëlle ^a,c   Tassan, Jean Pierre ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

HeLa; M phase; Protein degradation; Xenopus

Indexed keywords

CELL CYCLE PROTEIN; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MESSENGER RNA; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EMBRYO; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL CYCLE; CELL CYCLE M PHASE; CELL LEVEL; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; HELA CELL; HUMAN; HUMAN CELL; INTERPHASE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA PROCESSING; XENOPUS;

EID: 77953811391     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.04.019     Document Type: Article

References (33)

1. Heyer B.S., Warsowe J., Solter D., Knowles B.B., Ackerman S.L. New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse egg and preimplantation embryo. Mol. Reprod. Dev. 1997, 47:148-156.
2. Gil M., Yang Y., Lee Y., Choi I., Ha H. Cloning and expression of a cDNA encoding a novel protein serine/threonine kinase predominantly expressed in hematopoietic cells. Gene 1997, 195:295-301.
3. Blot J., Chartrain I., Roghi C., Philippe M., Tassan J.-P. Cell cycle regulation of pEg3, a new Xenopus protein kinase of the KIN1/PAR-1/MARK family. Dev. Biol. 2002, 241:327-338.
4. Davezac N., Baldin V., Blot J., Ducommun B., Tassan J.P. Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene 2002, 21:7630-7641.
5. Badouel C., Korner R., Frank-Vaillant M., Couturier A., Nigg E.A., Tassan J.P. M-phase MELK activity is regulated by MPF and MAPK. Cell Cycle 2006, 5:883-889.
6. Nagase T., Seki N., Ishikawa K., Tanaka A., Nomura N. Prediction of the coding sequences of unidentified human genes. V. The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res. 1996, 3:17-24.
7. Gray D., Jubb A.M., Hogue D., Dowd P., Kljavin N., Yi S., Bai W., Frantz G., Zhang Z., Koeppen H., de Sauvage F.J., Davis D.P. Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. Cancer Res. 2005, 65:9751-9761.
8. Liu G., Yuan X., Zeng Z., Tunici P., Ng H., Abdulkadir I.R., Lu L., Irvin D., Black K.L., Yu J.S. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 2006, 5:67.
9. Marie S.K., Okamoto O.K., Uno M., Hasegawa A.P., Oba-Shinjo S.M., Cohen T., Camargo A.A., Kosoy A., Carlotti C.G., Toledo S., Moreira-Filho C.A., Zago M.A., Simpson A.J., Caballero O.L. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int. J. Cancer 2008, 122:807-815.
10. Nakano I., Masterman-Smith M., Saigusa K., Paucar A.A., Horvath S., Shoemaker L., Watanabe M., Negro A., Bajpai R., Howes A., Lelievre V., Waschek J.A., Lazareff J.A., Freije W.A., Liau L.M., Gilbertson R.J., Cloughesy T.F., Geschwind D.H., Nelson S.F., Mischel P.S., Terskikh A.V., Kornblum H.I. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. J. Neurosci. Res. 2008, 86:48-60.
11. Pickard M.R., Green A.R., Ellis I.O., Caldas C., Hedge V.L., Mourtada-Maarabouni M., Williams G.T. Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer. Breast Cancer Res. 2009, 11:R60.
12. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A.M. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9309-9314.
13. Nakano I., Paucar A.A., Bajpai R., Dougherty J.D., Zewail A., Kelly T.K., Kim K.J., Ou J., Groszer M., Imura T., Freije W.A., Nelson S.F., Sofroniew M.V., Wu H., Liu X., Terskikh A.V., Geschwind D.H., Kornblum H.I. Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J. Cell Biol. 2005, 170:413-427.
14. Mirey G., Chartrain I., Froment C., Quaranta M., Bouche J.P., Monsarrat B., Tassan J.P., Ducommun B. CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis. Cell Cycle 2005, 4:806-811.
15. Vulsteke V., Beullens M., Boudrez A., Keppens S., Van Eynde A., Rider M.H., Stalmans W., Bollen M. Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1. J. Biol. Chem. 2004, 279:8642-8647.
16. Lin M.L., Park J.H., Nishidate T., Nakamura Y., Katagiri T. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of the Bcl-2 family. Breast Cancer Res. 2007, 9:R17.
17. Jung H., Seong H.A., Ha H. Murine protein serine/threonine kinase 38 activates apoptosis signal-regulating kinase 1 via Thr 838 phosphorylation. J. Biol. Chem. 2008, 283:34541-34553.
18. Chartrain I., Couturier A., Tassan J.P. Cell cycle dependent cortical localization of pEg3 protein kinase in Xenopus and human cells. Biol. Cell 2006, 98:253-263.
19. Whitfield M.L., Sherlock G., Saldanha A.J., Murray J.I., Ball C.A., Alexander K.E., Matese J.C., Perou C.M., Hurt M.M., Brown P.O., Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 2002, 13:1977-2000.
20. Black E.P., Huang E., Dressman H., Rempel R., Laakso N., Asa S.L., Ishida S., West M., Nevins J.R. Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res. 2003, 63:3716-3723.
21. Verlinden L., Eelen G., Beullens I., Van Camp M., Van Hummelen P., Engelen K., Van Hellemont R., Marchal K., De Moor B., Foijer F., Te Riele H., Beullens M., Bollen M., Mathieu C., Bouillon R., Verstuyf A. Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1, 25-dihydroxyvitamin D3. J. Biol. Chem. 2005, 280:37319-37330.
22. Harlow E., Lane D. Antibodies: A Laboratory Manual 1988.
23. Cubizolles F., Legagneux V., Le Guellec R., Chartrain I., Uzbekov R., Ford C., Le Guellec K. pEg7, a new Xenopus protein required for mitotic chromosome condensation in egg extracts. J. Cell Biol. 1998, 143:1437-1446.
24. Chantret I., Rodolosse A., Barbat A., Dussaulx E., Brot-Laroche E., Zweibaum A., Rousset M. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J. Cell Sci. 1994, 107(Pt 1):213-225.
25. Ding Q.M., Ko T.C., Evers B.M. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4. Am. J. Physiol. 1998, 275:C1193-C1200.
26. Evers B.M., Ko T.C., Li J., Thompson E.A. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells. Am. J. Physiol. 1996, 271:G722-G727.
27. Pandrea I.V., Carriere V., Barbat A., Cambier D., Dussaulx E., Lesuffleur T., Rousset M., Zweibaum A. Postmitotic differentiation of colon carcinoma caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity. Exp. Mol. Pathol. 2000, 69:37-45.
28. Tian J.Q., Quaroni A. Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation. Am. J. Physiol. 1999, 276:C1245-C1258.
29. Newport J., Kirschner M. A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage. Cell 1982, 30:675-686.
30. Newport J., Kirschner M. A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell 1982, 30:687-696.
31. Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell 2008, 31:438-448.
32. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10762-10767.
33. Rolli-Derkinderen M., Sauzeau V., Boyer L., Lemichez E., Baron C., Henrion D., Loirand G., Pacaud P. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells. Circ. Res. 2005, 96:1152-1160.